Nausea may occur when appetite suppression, delayed gastric emptying, food choices, meal size, or dose escalation exceeds what the patient can tolerate
Berberine vs GLP-1 Medications: What's the Difference, and Which Option Might Be Right for You
e51784 (2014)
A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects
As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
If thyroid-related events were not reported in publication, these data were extracted from the Serious Adverse Events portion of ClinicalTrials.gov